• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Industrials·DCO
Held by 3 Gurus
Share

Ducommun Incorporated Stocks

$ 172.85Last Updated 05.10.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

$ 2.65B

$ 172.85
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.01%

Fund

Point72 Asset Management, L.P.

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Bridgewater Associates

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Steven CohenPoint72 Asset Management, L.P.0.0%+0.01%
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.0%+0.00%
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Ducommun Incorporated, an established company founded in 1849 and based in Santa Ana, California, specializes in delivering advanced engineering and manufacturing solutions. Primarily, it caters to critical sectors within the United States, such as the aerospace and defense, industrial, and medical fields. The company's operations are divided into two principal segments: Electronic Systems and Structural Systems. The Electronic Systems division produces a wide array of sophisticated components. These offerings encompass various connectivity and wiring solutions like cable assemblies, wire harnesses, and interconnect systems, as well as printed circuit board assemblies and more complex electronic, electromechanical, and mechanical sub-assemblies. This segment also provides lightning diversion systems, radar housings, aircraft electronics racks, shipboard communication and control enclosures, surge suppressors, and conformal shields. Additionally, it develops precision-engineered products such as illuminated pushbutton switches and control panels for aviation and testing, high-frequency microwave and millimeter switches/filters for radio frequency systems, and motors and resolvers for motion control applications. A significant aspect of this division is its contribution of engineering expertise to aerospace system design, development, integration, and testing. The Structural Systems division focuses on designing, engineering, and fabricating intricate structural elements. Its product range includes meticulously contoured aerospace components crafted from aluminum, titanium, and Inconel alloys. This segment also creates complete structural assemblies, such as winglets, engine components, and fuselage panels. Furthermore, it is responsible for advanced metal and composite bonded structures and assemblies, examples of which include aircraft wing spoilers, large fuselage skins, rotor blades for rotary-wing aircraft, flight control surfaces, engine parts, ammunition handling systems, and magnetic seals. Ducommun's extensive portfolio of products and services supports a diverse range of applications, spanning commercial and military aviation (both fixed-wing and rotary-wing platforms), space exploration programs, and various industrial and medical end-use markets.

Company Valuation

Overvalued
2/7

From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of DCO is 203 and suggests 17.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

10.10.2026 16:01

What's Important in Small-Cap Stocks: Risks Associated with Webull, Levi's Outlook, and Vaxcyte's Success

10.10.2026 13:01

How soon will the AI bubble burst? Will France infect the Eurozone? What's wrong with Levi's jeans?

10.10.2026 06:47

Moderna hits four-year high as NYT reports U.S. cancer vaccine effort

10.10.2026 04:58

Palantir shares hit a new high: Barclays followed Goldman in recommending a buy

10.10.2026 04:25

Apple has cut orders for parts for the new iPhones, according to media reports. Was demand lower than expected?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026